3/14
10:12 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at Wedbush from $42.00 to $43.00. They now have an "outperform" rating on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at Wedbush from $42.00 to $43.00. They now have an "outperform" rating on the stock.
3/14
08:04 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $49.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $49.00 to $50.00. They now have a "buy" rating on the stock.
3/13
07:30 am
trml
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Medium
Report
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
3/6
07:49 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at Wedbush. They set an "outperform" rating and a $42.00 price target on the stock.
High
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at Wedbush. They set an "outperform" rating and a $42.00 price target on the stock.
3/3
07:15 am
trml
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
Medium
Report
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
2/24
11:10 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $58.00 price target on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $58.00 price target on the stock.
1/27
07:00 am
trml
Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
Medium
Report
Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
1/10
07:30 am
trml
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
Medium
Report
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker